Cargando…

A novel quantitative prognostic model for initially diagnosed non-small cell lung cancer with brain metastases

BACKGROUND: The prognosis of non-small cell lung cancer (NSCLC) with brain metastases (BMs) had been researched in some researches, but the combination of clinical characteristics and serum inflammatory indexes as a noninvasive and more accurate model has not been described. METHODS: We retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaohui, Gu, Wenshen, Liu, Yijun, Wen, Xiaoyan, Tian, Liru, Yan, Shumei, Chen, Shulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367158/ https://www.ncbi.nlm.nih.gov/pubmed/35948974 http://dx.doi.org/10.1186/s12935-022-02671-2

Ejemplares similares

Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort
por: Steindl, Ariane, et al.
Publicado: (2019)

Treatment Patterns and Survival Outcomes of Non-Small Cell Lung Cancer Patients Initially Diagnosed With Brain Metastases in Real-World Clinical Practice
por: Chen, Xin-Ru, et al.
Publicado: (2020)

Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
por: Kaul, David, et al.
Publicado: (2015)

Two-session Radiosurgery as Initial Treatment for Newly Diagnosed Large, Symptomatic Brain Metastases from Breast and Lung Histology
por: Lovo, Eduardo E, et al.
Publicado: (2019)

Analyses of prognostic factors in cases of non-small cell lung cancer with multiple brain metastases
por: Gong, Xiaomei, et al.
Publicado: (2016)

An effective prognostic model for assessing prognosis of non-small cell lung cancer with brain metastases
por: Wang, Rong, et al.
Publicado: (2023)

Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases
por: Ramotar, Matthew, et al.
Publicado: (2019)

Prognostic Dynamic Nomogram Integrated with Inflammation-Based Factors for Non-Small Cell Lung Cancer Patients with Chronic Hepatitis B Viral Infection
por: Chen, Shulin, et al.
Publicado: (2018)

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases
por: Xu, Jian‐ping, et al.
Publicado: (2016)

Apatinib Monotherapy or Combination Therapy for Non-Small Cell Lung Cancer Patients With Brain Metastases
por: Xu, Jianping, et al.
Publicado: (2020)

Prognostic factors and outcome of surgically treated patients with brain metastases of non‐small cell lung cancer
por: She, Chunhua, et al.
Publicado: (2018)

External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer
por: Nieder, Carsten, et al.
Publicado: (2022)

ALK-Brain Prognostic Index—Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases
por: Tsakonas, Georgios, et al.
Publicado: (2020)

Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
por: Furtner, Julia, et al.
Publicado: (2018)

Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non–small cell lung cancer brain metastases
por: Steindl, Ariane, et al.
Publicado: (2020)

The Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Owen, Scott, et al.
Publicado: (2014)

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2021)

Small Vessel Ischemic Disease of the Brain and Brain Metastases in Lung Cancer Patients
por: Mazzone, Peter J., et al.
Publicado: (2009)

Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer
por: Wu, Xiao-Tian, et al.
Publicado: (2020)

SURG-05. Neurosurgery for brain metastases from non-small cell lung cancer: survival outcome and prognostic factors
por: Li, De-pei, et al.
Publicado: (2021)

Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non-small cell lung cancer
por: Zhang, Yijun, et al.
Publicado: (2021)

State-of-the-art considerations in small cell lung cancer brain metastases
por: Lukas, Rimas V., et al.
Publicado: (2017)

Systemic treatment of non-small cell lung cancer brain metastases
por: Cedrych, Ida, et al.
Publicado: (2016)

Radiosurgery for small-cell lung cancer brain metastases: a review
por: Robin, Tyler P., et al.
Publicado: (2020)

The Immune Microenvironment in Brain Metastases of Non-Small Cell Lung Cancer
por: Luo, Lumeng, et al.
Publicado: (2021)

Stereotactic Radiosurgery for Brain Metastases in Patients With Small Cell Lung Cancer
por: Wang, Victoria H., et al.
Publicado: (2023)

The Impact of Chemosensitivity on the Outcome of Brain Metastases in Small-Cell Lung Cancer: A Retrospective Analysis
por: Ma, Jintao, et al.
Publicado: (2022)

Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases
por: Wang, Jing, et al.
Publicado: (2020)

Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer
por: Nian, Rui, et al.
Publicado: (2022)

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors
por: Jacot, W, et al.
Publicado: (2001)

Prognostic value of lactate dehydrogenase in non-small cell lung cancer patients with brain metastases: a retrospective cohort study
por: Wang, Shuting, et al.
Publicado: (2022)

Prognostic Factors among Brain Metastases in Newly Diagnosed Ovary Cancer: A Large Real-world Study
por: Xi, Sujuan, et al.
Publicado: (2020)

Cutaneous Metastases as Initial Presentation of Lung Carcinoma
por: Sharma, Gaurav, et al.
Publicado: (2021)

Risk factors of brain metastases as initial failure in completely resected stage IIIA(N2) non-small cell lung cancer
por: Zhang, Qin, et al.
Publicado: (2020)

Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain Metastases
por: Zheng, Lie, et al.
Publicado: (2022)

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma
por: Xu, Jianping, et al.
Publicado: (2016)

Quantitative protein expression of blood‐brain barrier transporters in the vasculature of brain metastases of patients with lung and breast cancer
por: Bao, Xun, et al.
Publicado: (2021)

Cystic brain metastases in ALK-rearranged non-small cell lung cancer
por: Marta, Guilherme Nader, et al.
Publicado: (2018)

Risk factors for brain metastases in patients with non–small‐cell lung cancer
por: An, Ning, et al.
Publicado: (2018)

Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases
por: Huang, Richard S P, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_smkc8q10lqfrsfqtugvq40skb0